Delta Neutrophil Index for the Prediction of the Development of Sepsis-Induced Acute Kidney Injury in the Emergency Department

Shock. 2019 Oct;52(4):414-422. doi: 10.1097/SHK.0000000000001299.

Abstract

Background and purpose: The early prediction of acute kidney injury (AKI) in sepsis and provision of timely treatment may improve outcomes. We investigated the efficacy of the delta neutrophil index (DNI)-which reflects the fraction of immature granulocytes-in predicting sepsis-induced AKI and 30-day mortality in cases of severe sepsis or septic shock.

Methods: This retrospective, observational cohort study was performed with patients prospectively integrated in a critical pathway of early-goal-directed therapy /SEPSIS. We analyzed adult sepsis patients admitted to the emergency department with normal kidney function or stage 1 disease, based on the Acute Kidney Injury Network classification, between January 1, 2014 and September 30, 2017. The outcomes were the development of sepsis-induced severe AKI within 7 days and 30-day mortality.

Results: A total of 346 patients were enrolled. An increase in the DNI values at Time-0 (odds ratio [OR], 1.060; P < 0.001) and Time-12 (OR, 1.086; P < 0.001) were strong independent predictors of severe AKI development. The increasing predictability of AKI was closely associated with a DNI ≥14.0% at Time-0 (OR, 7.238; P < 0.001) and ≥13.3% at Time-12 (OR, 18.089; P < 0.001). The development of severe AKI was an independent predictor of 30-day mortality (hazard ratio: 25.2, P < 0.001).

Conclusion: Higher DNI values are independent predictors of severe AKI development and 30-day mortality in sepsis. Physicians can use the DNI to quickly determine the severity of sepsis and initial treatment strategies without additional costs and effort.

Publication types

  • Clinical Trial
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / blood
  • Acute Kidney Injury* / etiology
  • Acute Kidney Injury* / mortality
  • Acute Kidney Injury* / therapy
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Disease-Free Survival
  • Emergency Service, Hospital*
  • Female
  • Hospital Mortality*
  • Humans
  • Male
  • Middle Aged
  • Neutrophils*
  • Renal Replacement Therapy
  • Retrospective Studies
  • Risk Factors
  • Shock, Septic* / blood
  • Shock, Septic* / complications
  • Shock, Septic* / mortality
  • Shock, Septic* / therapy
  • Survival Rate
  • Time Factors

Substances

  • Biomarkers